-
Purdue Researchers Create Prostate Cancer 'Homing Device' For Drug Delivery
7/7/2009
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease.
-
Tekmira Pharmaceuticals Initiates ApoB SNALP Phase 1 Clinical Trial
7/3/2009
Tekmira Pharmaceuticals Corporation (TSX:TKM) announced today that it has initiated a Phase 1 human clinical trial for ApoB SNALP.ApoB SNALP, Tekmira's lead RNAi therapeutic product candidate, is being developed as a treatment for patients with elevated low-density lipoprotein (LDL) cholesterol, or "bad" cholesterol, who are not well served by current therapy.
-
Pharmaceutical Development Services Establishes U.S. Base For Expansion
7/2/2009
Represented in America by Dr. Jeff Rudolph, PDS will guide U.S. pharmaceutical companies wanting to develop into Europe, covering the major subject areas of regulation, quality management, European legal framework and the sourcing of local contractors for development.
-
Biologics Dominate The Autoimmune Market But Small Molecules Still Have Some Fight Left, Says Cutting Edge Information
7/1/2009
Biological drugs are the big winners in the market for autoimmune disorders.
-
U.S. Marshals Seize Drug Products Manufactured By Caraco Pharmaceutical Laboratories Ltd.
6/30/2009
U.S. Marshals, at the request of the Food and Drug Administration, recently seized drug products manufactured by Caraco Pharmaceutical Laboratories Ltd. (Caraco), at the company’s Michigan facilities in Detroit, Farmington Hills, and Wixom.
-
GSK And Chroma Therapeutics Form Alliance To Develop Novel Macrophage-Targeted Drugs
6/24/2009
GlaxoSmithKline and Chroma Therapeutics Limited announced recently a collaboration to develop macrophage-targeted compounds using Chroma’s proprietary esterase-sensitive motif (ESM) technology, which adds amino acid esters to compounds with the aim of targeting the compounds to specific cells in the inflammatory disease process.
-
49 Station Tablet Press Introduced By Sejong / Key International
6/18/2009
Designed for mid to high production volumes, the MRC Series consisted of 30 (D) and 36 (B) station single sided and 45 station (B) and (BB) double sided tablet presses.
-
Brooks Instrument Completes Acquisition Of Celerity's Instrumentation Division
6/17/2009
Brooks Instrument, a world-leading provider of flow measurement and control devices and level gauges, recently announced that it has acquired certain assets of Celerity’s Instrumentation division, a technology leader in precision instruments and advanced gas and liquid delivery solutions for the global semiconductor, solar, and electronics industries. Financial terms of the transaction were not disclosed.
-
Genilogix Announces The Availability Of QC eApprove
6/16/2009
Genilogix recently announced the availability of QC eApprove.
-
Possible High Levels Of Active Ingredient Leads To Class 1 Recall
6/12/2009
All remaining stock of four batches of Oxybutynin Hydrochloride 5mg tablets is being recalled by Niche Generics Ltd due to the possibility they could contain too much of the active ingredient.
